Is remicade for crohn's?

Who Makes Remicade for Crohn's?

Remicade, also known as infliximab, is a medication developed by Janssen Biotech, Inc., a subsidiary of Johnson & Johnson. It was first approved by the US FDA in 1998 for treating rheumatoid arthritis, and later expanded to include approval for other conditions such as Crohn's disease and ulcerative colitis [1].

What Is Remicade Used for in Crohn's?

Remicade is a type of biologic medication known as a tumor necrosis factor-alpha (TNF-alpha) inhibitor. It works by blocking the action of TNF-alpha, a protein that causes inflammation in the body. For Crohn's disease, Remicade is used to reduce inflammation and manage symptoms such as diarrhea, abdominal pain, and weight loss [2].

How Is Remicade Administered for Crohn's?

Remicade is typically administered intravenously (IV) through a vein in the arm. The dosage and frequency of administration may vary depending on the patient's specific needs and response to treatment [3].

What Are the Benefits of Remicade for Crohn's?

Remicade has been shown to be effective in reducing symptoms and inducing and maintaining clinical remission in patients with Crohn's disease. It is available as a standalone treatment or in combination with other medications [4].

Are There Any Side Effects or Risks?

Remicade can cause side effects such as headaches, fatigue, and injection site reactions. In some cases, it can also increase the risk of infections, including rare but serious infections like tuberculosis [5].

When Does Exclusivity Expire?

The Remicade patent, which was first approved in 2006, is set to expire in 2023 [6], allowing generic versions of the medication to enter the market.

Can Biosimilars Enter the Market Before Patent Expiry?

Biosimilars, such as Inflectra and Remicade biosimilar by Pfizer/BioNTech, have already been approved by the US FDA for use in treating Crohn's disease. These biosimilars work similarly to Remicade, but with slightly different active pharmaceutical ingredients [7].

Sources:

[1] DrugPatentWatch.com
[2] WebMD
[3] MedlinePlus
[4] AstraZeneca
[5] RXList
[6] Pharmaceutical Research and Manufacturers of America
[7] FiercePharma

List of Sources:

1. DrugPatentWatch.com
2. WebMD
3. MedlinePlus
4. AstraZeneca
5. RXList
6. Pharmaceutical Research and Manufacturers of America
7. FiercePharma